Effects of ketamine on hypoxic pulmonary vasoconstriction in the isolated perfused lungs of endotoxaemic mice

European Journal of Anaesthesiology

Volumn 27, Issue 1, 2010, Pages 61-66

  Busch, Cornelius J ^a   Spöhr, Fabian A ^b   Motsch, Johann ^a   Gebhard, Martha M ^a   Martin, Eike O ^a   Weimann, Jörg ^c,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Sankt Gertrauden Hospital   (Germany)

Author keywords

Hypoxic pulmonary vasoconstriction; Isolated perfused mouse lung; Ketamine; Sepsis

Indexed keywords

KETAMINE; LIPOPOLYSACCHARIDE; ANESTHETIC AGENT; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; ENDOTOXEMIA; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; MOUSE; NONHUMAN; PULMONARY VASCULAR DISEASE; SEPSIS; ANIMAL; ANOXIA; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECT; LUNG CIRCULATION; METABOLISM; PATHOLOGY; PULMONARY ARTERY; TIME; VASOCONSTRICTION;

ANESTHETICS, DISSOCIATIVE; ANIMALS; ANOXIA; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; KETAMINE; LIPOPOLYSACCHARIDES; MICE; OXYGEN; PULMONARY ARTERY; PULMONARY CIRCULATION; TIME FACTORS; VASOCONSTRICTION;

EID: 77449148430     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328329affb     Document Type: Article

References (32)

1. Voelkel NF. Mechanisms of hypoxic pulmonary asoconstriction. Am Rev Respir Dis 1986; 133:1186-1195.
2. Ward JP, Aaronson PI. Mechanisms of hypoxic pulmonary vasoconstriction: can anyone be right? Respir Physiol 1999; 115:261-271.
3. Archer SL, WuXC, Thebaud B, et al. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells. Circ Res 2004; 95:308-318.
4. Bonnet S, Archer SL. Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension. Pharmacol Ther 2007; 115:56-69.
5. Chang SW, Feddersen CO, Henson PM, Voelkel NF. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 1987; 79:1498-1509.
6. Theissen JL, Loick HM, Curry BB, et al. Time course of hypoxic pulmonary vasoconstriction after endotoxin infusion in unanesthetized sheep. J Appl Physiol 1991; 70:2120-2125.
7. Spöhr F, Cornelissen AJ, Busch C, et al. Role of endogenous nitric oxide in endotoxin-induced alteration of hypoxic pulmonary vasoconstriction in mice. Am J Physiol Heart Circ Physiol 2005; 289:H823-H831.
8. Dantzker DR, Brook CJ, Dehart P, et al. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 1979; 120:1039-1052.
9. Marshall BE, Marshall C, Frasch F, Hanson CW. Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution. 1. Physiologic concepts. Intensive Care Med 1994; 20:291-297. (Pubitemid 24132371)
10. Bjertnaes LJ. Hypoxia-induced vasoconstriction in isolated perfused lungs exposed to injectable or inhalation anesthetics. Acta Anaesthesiol Scand 1977; 21:133-147.
11. Lennon PF, Murray PA. Attenuated hypoxic pulmonary vasoconstriction during isoflurane anesthesia is abolished by cyclooxygenase inhibition in chronically instrumented dogs. Anesthesiology 1996; 84:404-414.
12. Beck DH, Doepfmer UR, Sinemus C, et al. Effects of sevoflurane and propofol on pulmonary shunt fraction during one-lung ventilation for thoracic surgery. Br J Anaesth 2001; 86:38-43.
13. Martin J, Franck M, Fischer M, Spies C. Sedation and analgesia in German intensive care units: how is it done in reality? Results of a patient-based survey of analgesia and sedation. Intensive Care Med 2006; 32:1137-1142.
14. Liu HT, Hollmann MW, Liu WH, et al. Modulation of NMDA receptor function by ketamine and magnesium. Part I. Anesth Analg 2001; 92:1173-1181.
15. Hirota K, Okawa H, Appadu BL, et al. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Anesthesiology 1999; 90:174-182.
16. White PF, Way WL, Trevor AJ. Ketamine: its pharmacology and therapeutic uses. Anesthesiology 1982; 56:119-136.
17. Ogawa K, Tanaka S, Murray PA. Inhibitory effects of etomidate and ketamine on endothelium-dependent relaxation in canine pulmonary artery. Anesthesiology 2001; 94:668-677.
18. Lee TS, Hou X. Vasoactive effects of ketamine on isolated rabbit pulmonary arteries. Chest 1995; 107:1152-1155.
19. Gassner S, Cohen M, Aygen M, et al. The effect of ketamine on pulmonary artery pressure. An experimental and clinical study. Anaesthesia 1974; 29:141-146.
20. Linehan JH, Haworth ST, Nelin LD, et al. A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves. J Appl Physiol 1992; 73:987-994.
21. Weimann J, Bloch KD, Takata M, et al. Congenital NOS2 deficiency protects mice from LPS-induced hyporesponsiveness to inhaled nitric oxide. Anesthesiology 1999; 91:1744-1753.
22. Tweed WA, Minuck M, Mymin D. Circulatory responses to ketamine anesthesia. Anesthesiology 1972; 37:613-619.
23. Takahashi K, Shima T, Koga Y, Iwatsuki K. Effect of ketamine hydrochloride (Ketalar) on the pulmonary hemodynamics. Masui 1971; 20:842-846.
24. Nakayama M, Murray PA. Ketamine preserves and propofol potentiates hypoxic pulmonary vasoconstriction compared with the conscious state in chronically instrumented dogs. Anesthesiology 1999; 91:760-771.
25. Maruyama K, Maruyama J, Yokochi A, et al. Vasodilatory effects of ketamine on pulmonary arteries in rats with chronic hypoxic pulmonary hypertension. Anesth Analg 1995; 80:786-792.
26. Kaye AD, Banister RE, Anwar M, et al. Pulmonary vasodilation by ketamine is mediated in part by L-type calcium channels. Anesth Analg 1998; 87:956-962.
27. Chen RM, Chen TL, Lin YL, et al. Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells by down-regulating endothelial nitric oxide synthase expression and intracellular calcium levels. Crit Care Med 2005; 33:1044-1049.
28. Martin J, Bäsell K, Bürkle H, et al. Analgesia and sedation in intensive care medicine. Anästh Intensivmed 2005; 46:S1-S20.
29. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA 2000; 283:1451-1459.
30. Payen JF, Chanques G, Mantz J, et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007; 106:687-695.
31. Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003; 63:649-671.
32. Williams GD, Philip BM, Chu LF, et al. Ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension undergoing sevoflurane anesthesia and spontaneous ventilation. Anesth Analg 2007; 105:1578-1584.